Yantai Dongcheng Biochemicals, based in Shangdong, is The Japanese API sector will be represented by Itochu Chemical
one of the largest biochemical API manufacturers in China. Frontier, whose Pharma-Life Science division consists of three
Product offerings specifi cally for the pharmaceutical and food business units: a pharmaceutical unit that can coordinate
industries include heparin sodium derivatives, chondroitin sulphate the outsourcing of the entire process from drug discovery to
derivatives, hyaluronic acid, collagen and glucosamine. commercialisation; a second pharmaceutical unit that provides
APIs, pharmaceutical intermediates, and generics; and a life
Welding of Germany trades in APIs, excipients and natural
science unit that focuses on dietary products that contribute to
substances for human and veterinary medicines, and also offers
healthy lifestyles.
development, registration and marketing of generic drugs. Other
products and services include additives for the food and feed
PCAS, of Longjumeau in France, operates eight chemical plants
industries, and an extensive range of services covering the fi elds of
in Europe and North America, and offers services relating to
quality management, marketing and regulatory affairs.
process development and manufacturing from kilo-lab to tonne
scale. Raw material synthesis takes place in dedicated facilities
Helm’s offerings include APIs and fi nished formulations from
(cGMP, ISO 9001), together with custom manufacture of APIs, key
GMP-certifi ed manufacturers, quality assurance system and
intermediates and pharma polymers.
quality control, local distribution, evaluation and submission of
CTD/CEP documentation, preparation and submission of dossiers
A German manufacturer of highly pure and active precious metal
for marketing authorisations, market analysis, patent research/
chemicals and catalysts, Umicore PMC, recently opened a new
application/monitoring, generic drug development, and medical
cGMP-, ISO 9001- and 14001- and USP-, EP- and JP compliant
disposables.
plant for the manufacture of cisplatin, carboplatin, oxaliplatin and
other oncology-related platinum APIs.
Another German company is Midas Pharma, whose aim is to be
the partner of fi rst choice for APIs, biosimilars, custom synthesis,
Dipharma Francis is a major Italian player in the generic API
contract manufacturing, registration dossiers, international
sector. Four FDA-approved manufacturing sites, a fully equipped
licensing, regulatory services, self-medication and platform
R&D centre, an internal IP department and an experienced quality
technologies.
and regulatory organisation guarantee customers an innovative
professional service.
Hapila is involved in the development of APIs, purifi cation
processes using the HAPIpur technology and particle design
The Maltese company Amino Chemicals, part of the Dipharma
procedures for fi nished APIs.
Group, is an FDA-approved company producing high quality
APIs in full cGMP compliance. Thanks to the favourable patent
5
Recordati is a research-based Italian company with worldwide
environment in Malta and consolidated expertise in innovative
operations and customers in more than 100 countries. It has two
chemical synthesis, Amino must rate as an attractive partner for
fi ne chemical facilities in operation for the production of APIs and
the supply of generic APIs.
advanced intermediates. Each manufacturing site has an R&D
centre, including a pilot plant, for scaling up of new products/
Covex is a Spanish manufacturer of chemical, pharmaceutical
technologies. Another Italian company, Procos, manufactures APIs
and nutraceutical products. Since its foundation in 1977, it has
and intermediates for the pharmaceutical market, in the generic
been engaged in permanent R&D, especially of vinca alkaloids.
and custom manufacturing fi eld. Its core know-how relates
The company sells raw materials for vinpocetine, vincamine,
to high-pressure techniques such as catalytic hydrogenations,
vinburnine, vinponature and vincagenol in 55 countries. Covex
carboxylations and reductive aminations.
also sells vinpocetine in a fi nished dosage form in 28 countries.
India’s Reliance Life Sciences is a research-driven,
The Swedish specialist contract research organisation Syntagon
biotechnology-led, life sciences organisation with interests in the
has recently renewed its GMP certifi cation for the manufacture of
medical, plant and industrial biotechnology sectors. Specifi cally,
clinical APIs following an audit by the Swedish Medical Products
these relate to biopharmaceuticals, pharmaceuticals, clinical
Agency. Syntagon specialises in the synthesis of small molecules
research services, regenerative medicine, molecular medicine,
under GMP conditions.
novel therapeutics, biofuels, plant biotechnology and industrial
Archimica’s focus is high-tech building blocks, intermediates and
biotechnology.
APIs. Based in Germany, with seven production sites in Europe
Biocon, based in Bangalore, focuses on unmet medical needs
and the US, the fi rm conducts cryogenic reactions, especially
in cancer, diabetes and infl ammatory diseases, and offers novel
for boronic acids, Pd-catalysed cross-couplings, hydrogenations,
therapies on a platform of affordable innovation. Harman
phosgenations, heterocycles, enzymatic chemistries, nitrations and
Finochem, meanwhile, has two manufacturing sites for APIs at
sterile fi ltrations.
Aurangabad and one at Vapi, with a capacity of 350,000 litres. Amano Enzyme Europe is an API and intermediates player based
Its facilities comply with cGMP norms as per US FDA, ICH in Chipping Norton, UK. HEC Pharm is a Dongguan, China-
Q7A, TGA, PIC, WHO-GMP, Schedule M and Japanese Foreign based fi rm with activities spanning APIs, contract manufacturing,
Accreditation. raw materials/intermediates and excipients/drug formulation.
Scrip World Pharmaceutical News Supplement August 2009
cphi.com | icsexpo.com | p-mec.com | bioph-online.com
wherepharmameets.com | scripnews.com
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44